Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT6EW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,748
Award facts
- Contract value 100% obligated
- $12,748.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,748.35 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pen injections, with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider within the federal supply chain, specializing in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical needs across multiple therapeutic domains, including diabetes medications and specialized medical supplies. This delivery order for Wegovy, a GLP-1 receptor agonist used in diabetes and weight management, reflects the company's ongoing role in supplying essential pharmaceutical products to support the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FT6EW?
SPE2DR26FT6EW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FT6EW worth?
The government has obligated $12,748 on SPE2DR26FT6EW.
Is contract SPE2DR26FT6EW an order under another contract?
Yes. SPE2DR26FT6EW is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT6EW competed?
The extent of competition for SPE2DR26FT6EW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award